5
total announcements
532154.BO · 15 min delayed
Johnson Pharmacare Ltd
Johnson Pharmacare Ltd has submitted an undertaking stating that Regulation 32 of SEBI (LODR) Regulations, 2015 is not applicable to the company for the quarter ended on June 30th, 2026, as no public issue, rights issue, or preferential issue was made during this period.
Johnson Pharmacare Ltd
Johnson Pharmacare Ltd has submitted its un-audited financial results for the quarter ended June 30th, 2026, along with a limited review report. The results were approved by the Board of Directors on August 13th, 2026.
Johnson Pharmacare Ltd
Johnson Pharmacare Ltd's board of directors has approved the company's unaudited financial results for the quarter ended June 30, 2026, along with a limited review report. The results were reviewed by the company's statutory auditor, VRSK & Associates, and found to be in compliance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Johnson Pharmacare Ltd
Johnson Pharmacare Ltd has informed the exchange that its board of directors has approved the shifting of its registered office address from the existing address to a new address within the local limits.
Johnson Pharmacare Ltd
Johnson Pharmacare Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 13/08/2026 to consider and approve the Un-Audited (Standalone) Financial Results for the Quarter ended on 30th June, 2026.